Kellie N. Smith
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 21
- CAR-T cell therapy research 7
- Immunology 20
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 6
- Co-authors
- Drew M. Pardoll (14 shared papers)Patrick M. Forde (13 shared papers)Suzanne L. Topalian (8 shared papers)Leisha A. Emens (1 shared paper)Mark Yarchoan (1 shared paper)Valsamo Anagnostou (15 shared papers)Jiajia Zhang (11 shared papers)Franck Housseau (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Cell Reports Medicine (2 papers)Journal of Clinical Investigation (2 papers)Frontiers in Immunology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Kellie N. Smith
39 papers receiving 750 citations
Kellie N. Smith's Hit Papers
Peers
Comparison fields: 5 of 71
- Immunology 352
- Oncology 409
- Virology 67
- Pulmonary and Respiratory Medicine 174
- Infectious Diseases 77
Countries citing papers authored by Kellie N. Smith
This map shows the geographic impact of Kellie N. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie N. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie N. Smith more than expected).
Fields of papers citing papers by Kellie N. Smith
This network shows the impact of papers produced by Kellie N. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie N. Smith. The network helps show where Kellie N. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Kellie N. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy Hit paper breakdown → | 2023 | 153 |
| 2 | 2016 | 102 | |
| 3 | 2018 | 99 | |
| 4 | 2023 | 46 | |
| 5 | 2023 | 44 | |
| 6 | 2019 | 29 | |
| 7 | 2013 | 28 | |
| 8 | 2019 | 22 | |
| 9 | 2017 | 22 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 18 | |
| 12 | 2016 | 17 | |
| 13 | 2024 | 15 | |
| 14 | 2016 | 15 | |
| 15 | 2020 | 14 | |
| 16 | 2014 | 14 | |
| 17 | 2025 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2013 | 9 | |
| 20 | 2016 | 9 |
About Kellie N. Smith
Kellie N. Smith is a scholar working on Oncology, Immunology, Virology, Surgery and Molecular Biology, having authored 42 papers that have together received 756 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (11 papers), HIV Research and Treatment (9 papers), CAR-T cell therapy research (7 papers), T-cell and B-cell Immunology (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and vaccines and immunoinformatics approaches (4 papers). The work is most often cited by research in Immunology (352 citations), Oncology (409 citations), Virology (67 citations), Pulmonary and Respiratory Medicine (174 citations) and Infectious Diseases (77 citations). Kellie N. Smith has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Drew M. Pardoll, Patrick M. Forde, Suzanne L. Topalian, Leisha A. Emens, Mark Yarchoan, Valsamo Anagnostou, Jiajia Zhang, Franck Housseau, Julie R. Brahmer and Ada Tam. Their work appears in journals such as Journal of Clinical Oncology, Cell Reports Medicine, Journal of Clinical Investigation, Frontiers in Immunology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.